Identification of intracellular carriers for the endocannabinoid anandamide
about
Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugsAnandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashionFetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids SignalingOf mice and (wo)men: factors influencing successful implantation including endocannabinoidsN-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leadsExploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporterCrystallographic study of FABP5 as an intracellular endocannabinoid transporterStructural Basis for Ligand Regulation of the Fatty Acid-binding Protein 5, Peroxisome Proliferator-activated Receptor / (FABP5-PPAR / ) Signaling PathwayCannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the EvidenceRecent insights into the biological functions of liver fatty acid binding protein 1Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionKetoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrationsFatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brainLipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.From Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System.Cannabinoids as novel anti-inflammatory drugs.Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.Interactions of Cannabinoids With Biochemical SubstratesFatty-acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila.Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.Pitfalls and solutions in assaying anandamide transport in cellsEndocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.Quantification of brain endocannabinoid levels: methods, interpretations and pitfallsThe endocannabinoid system as a target for the treatment of neurodegenerative disease.The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.Differences in the endocannabinoid system of sperm from fertile and infertile men.Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.Therapeutic Opportunities through the Modulation of Endocannabinoid Transport.Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injuryFabp3 inhibits proliferation and promotes apoptosis of embryonic myocardial cells.Role of FAAH-like anandamide transporter in anandamide inactivation.Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.Differential expression profile of long non-coding RNAs during differentiation of cardiomyocytes.Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia.Endocannabinoid tone versus constitutive activity of cannabinoid receptors.Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
P2860
Q21090833-FE4BABE3-1843-4434-A956-7CB57C0220DAQ24598965-EA3C4589-EA20-4118-8011-355EDE5B018FQ26777055-F10A0FEE-D468-410D-A587-EC3DABE66383Q26992063-6F13837E-47AB-4BCF-8F1C-3EBDB3DC272CQ27011679-9B3966CC-5314-4B86-8442-4B8AC2FFA8E0Q27330950-90387575-64DE-480B-A077-D1B573C6B87AQ27681752-BF80D920-0002-4CD9-A229-EE1819597CE9Q27682758-319AA503-249E-4254-9AA2-3B47F09D3099Q28075499-B08EA555-9D28-4530-95A1-A5BD1886B504Q28268205-CAC99BA0-A413-4FAB-A9A9-376456FCA44FQ28283718-72EDC414-0C7F-43DF-9008-CF4F005631B6Q28539116-A6CA6E7D-5D40-4FCF-A7E2-859B103A9401Q33556230-3B7AAB68-7819-4843-BB4C-1BB9F7C13BD8Q33594073-9A027ACD-266B-4C16-85B2-899BB79AAB82Q33610506-B4577578-7F91-4098-A6A7-FCAA3C64D85FQ33613330-9659831E-C47A-4290-8570-89EA5424AF09Q33664729-C0B2CF22-5A56-426A-99B7-F27E8BF94487Q33688381-0D0A9AA4-605A-4BC4-BD0B-08D0337788BDQ33714587-C5BBBF5C-8D0E-4B7A-8FAF-8E8EB4ACEA26Q33758351-24F2929B-8A26-43BC-8030-5417022815BEQ33813229-4A6C9589-8540-448C-AEFC-CC60F713DB3EQ33961812-3267586F-A4C6-452A-91ED-BB5206F90994Q33993270-26DF897E-E136-4109-83C2-1B4106AE50D9Q33997873-5B4C91DA-538E-4BED-8410-823379025BFEQ34098167-746CC8CB-3271-44AD-AED6-4923E6E12864Q34098196-1C6C092D-E9D8-4CE1-B991-78F89B7324DCQ34181605-39A0D94B-8D0D-4769-A7EF-FB9D4964F4B8Q34452217-C08690DD-608A-49EF-B7E8-5B8658AB77D8Q34461976-48133604-88A5-426C-B882-36EA05F3F360Q34538205-D66083E1-9981-4276-9548-0CBFFEC5C88EQ34632483-93830102-68EB-4D46-B70C-F14078531232Q34718182-27D7BBA6-7EE8-461D-B84C-52E370DDDB0FQ34734555-DCE5C08A-51E4-4C12-8C0F-67987C66CE8EQ35038747-5F0700B2-36AC-49AB-8930-0406D273176FQ35041271-C2A790F0-C447-4C09-9193-683414D9C27CQ35071134-4580DA7D-61E5-43F1-B2C5-A5B08EB41028Q35136471-AEBDA051-D1FF-4134-8D7A-F23FDBD15612Q35140182-E3472BEF-9EE8-4777-AD38-25044FAB7793Q35193265-85A7A8D1-9785-408B-8B51-8F06D5FD2657Q35216071-F246A8F1-BF61-4573-9A8C-70E9967E7FCB
P2860
Identification of intracellular carriers for the endocannabinoid anandamide
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Identification of intracellular carriers for the endocannabinoid anandamide
@ast
Identification of intracellular carriers for the endocannabinoid anandamide
@en
Identification of intracellular carriers for the endocannabinoid anandamide
@nl
type
label
Identification of intracellular carriers for the endocannabinoid anandamide
@ast
Identification of intracellular carriers for the endocannabinoid anandamide
@en
Identification of intracellular carriers for the endocannabinoid anandamide
@nl
prefLabel
Identification of intracellular carriers for the endocannabinoid anandamide
@ast
Identification of intracellular carriers for the endocannabinoid anandamide
@en
Identification of intracellular carriers for the endocannabinoid anandamide
@nl
P2093
P2860
P921
P3181
P356
P1476
Identification of intracellular carriers for the endocannabinoid anandamide
@en
P2093
Dale G Deutsch
Martin Kaczocha
Sherrye T Glaser
P2860
P304
P3181
P356
10.1073/PNAS.0901515106
P407
P577
2009-04-14T00:00:00Z